Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 410 followers
Latest posts
Last updated about 4 hours ago
Why the Real Risk in Hub Transition is Inertia
about 4 hours ago
Manufacturers often focus on the costs of hub transition. The bigger risk...
Inside Noble’s connected approach to patient support
about 6 hours ago
As self-administered therapies grow, pharma companies are rethinking how onboarding, training and...
Pharma Doesn’t Need Another Walled Garden. Daily Command Was Built to Be the Opposite
about 6 hours ago
In pharma, a wall doesn't just cost money, it stands between a...
Pfizer takes Litfulo to regulators in vitiligo challenge to Incyte, AbbVie
about 6 hours ago
In hopes of challenging Incyte’s topical JAK inhibitor Opzelura, Pfizer is headed...
YouTuber MrBeast welcomes Amgen to the channel, kicking off pediatric cancer funding effort
about 8 hours ago
In MrBeast's new “I Helped 100 Kids Fight Cancer" YouTube video, Amgen...
New CEO Garijo sketches out vision to reverse Sanofi's fortunes as Q2 delivers impressive sales beat
about 9 hours ago
In her inaugural earnings call as the new CEO of Sanofi, Belén...
Alnylam shares tank 27% as Amvuttra disappoints with ATTR outlook cut for 2026
about 9 hours ago
Alnylam’s stock price plummeted as much as 27% Thursday morning after disappointing...
Booming Dupixent sales fuel Regeneron's biggest quarter since pandemic
about 9 hours ago
Worldwide sales of Regeneron and Sanofi's Dupixent were up again in the...
RFK Jr.'s Gardasil litigation ties subject to fresh lawmaker scrutiny after Merck settlement
about 9 hours ago
Despite Robert F. Kennedy Jr. ultimately agreeing to divest referral fees tied...
Bristol Myers delays Cobenfy Alzheimer’s psychosis readout again amid another quarterly beat
about 10 hours ago
Investors awaiting Bristol Myers Squibb’s key Alzheimer’s psychosis readout for Cobenfy and...
Lilly, Resilience commit $750M to boost US diabetes, obesity med production
about 12 hours ago
Eli Lilly has doubled down on its partnership with CDMO Resilience as...
Viatris runs into FDA roadblock after advertising on-the-go use of cystic fibrosis inhaler
about 13 hours ago
The FDA has rebuked Viatris for a direct-to-consumer video that allegedly misled...